A primary signal in the defense against intracellular infections is the cytokine IFN-g (1) . IFN-g is expressed by NK and NKT cells, CD8
+ cytotoxic T cells, and CD4 + Th1 cell subsets. During the initial CD4 + T cell maturation stage, a naive CD4 + T cell can polarize into various Th cell subsets including Th1 and Th2 subsets (2) . Th2 cells must repress IFNG. This IFNG repression in Th2 cells is dependent upon the noncoding segment of the genome. Mice carrying an 8.6-kb transgene of the human IFNG gene fail to repress IFNG in Th2 cells (3) . In contrast, mice carrying a 190-kb bacterial artificial chromosome (BAC) transgene with IFNG and the surrounding noncoding region both correctly express human IFN-g in Th1 cells and repress human IFN-g production in Th2 cells (3) . As such, cell-type selective expression of human IFN-g depends upon the noncoding segment of the genome.
The majority of the conserved portion of the human genome is noncoding. Further, the majority of the human common single nucleotide polymorphisms associated with disease traits are noncoding (4) . As such, understanding the noncoding segments of the genome will be important to understanding human health. The noncoding portion of the genome includes various types of functional elements, including enhancers. Enhancers are thought to be necessary for driving tissue-specific, as well as species-specific, gene expression (5, 6) . Some genes are regulated by multiple, redundant enhancers, which some models propose are necessary to allow for expression under suboptimal signaling conditions (7) . As enhancers drive tissue-specific expression, and tissue-specific expression of IFNG is critical for protection from intracellular infections in humans (8) , a relevant question is the mechanism of how IFNG enhancers drive tissue-specific expression of IFNG.
Transcription factor binding to mouse Ifng distal regulatory elements is cell type and stimulus type specific. The transcription factors T-bet (9, 10), STAT4 (10), STAT5 (11, 12) , NF-kB family members (13) , and Runx3 (14) positively regulate IFNG expression and directly bind to distinct conserved noncoding sequences (CNS) of the mouse Ifng locus in a Th1-and stimulus-dependent manner. Transcription factor binding is accompanied by Th1-specific covalent histone modifications at conserved noncoding sequences (13, 15, 16) . These observations have led to the hypothesis that proper regulation of IFN g is conferred by transcription factor interactions with CNSs. In transgenic model systems, a mouse CNS 216 kb from the Ifng start site (mCNS216) is needed for Thy1.1 reporter expression from a mouse Ifng BAC (9) . In addition to mCNS216, additional mCNSs display enhancer activity in reporter assays (15, 17, 18) and also function with other Ifng CNS to synergistically stimulate transcriptional activity (18) .
Our understanding of human IFNG distal regulation in the setting of an intact genome is incomplete. We considered two nonexclusive hypotheses. First, CNSs may have redundant function in which each CNS is necessary for a fraction of IFNG expression in all responder cell types in response to diverse stimuli. Second, CNSs may possess unique functions such that each individual CNS provides a unique contribution to developmental decisions and stimulus specificity to achieve proper IFNG transcriptional regulation. To test these hypotheses, we employed an IFNG-BAC transgenic system (3, 14) . In this model, mice are created with a transgene that contains IFNG and surrounding regulatory regions with or without specific CNSs. Normal production of mouse IFN-g is not affected and serves as an internal control. We have previously characterized a conserved noncoding sequence 230 kb from the IFNG start site (CNS230) necessary for transge nic IFNG expression in T cells but not NK cells (14) . In this study, we extend those studies to comprehensively characterize IFNG CNS and detail the necessary function of CNS216, CNS24, CNS+20, and CNS+120. We find an essential role for CNS24 in effector/memory Th1 cells. CNS+20 is required for human IFNg production by in vivo-generated memory Th1 cells, as well as NKT cells. Lastly, we find that CNS216 has a repressive role in both Th1 and Th2 cells, opposite to what was found in the mouse BAC transgenic system (9) . In contrast, each of these CNSs, CNS216, CNS24, and CNS+20, contribute a fraction to IFNG transcription in NK cells. These results demonstrate that the necessary functions of distal regulatory elements are dependent upon developmental context, as well as species, cell type, and stimuli.
Materials and Methods
Mice and preparation of transgenic reporter lines C57BL/6 mice were obtained from The Jackson Laboratory (Bar Harbor, ME), housed in the Vanderbilt University animal facilities, and used between 4 and 5 wk of age. Preparation of human IFNG-BAC transgenic lines was preformed as described previously (14) . Briefly, human IFNG-BAC CTD-3002C24 was used to make 210-kb IFNG-BAC mice. Alternatively, CTD-3002C24 was moved into EL250 Escherichia coli, and CNS deletion was achieved using homologous recombination followed by flippase recognition target-mediated removal of the selection marker. Targeting primers are described in Supplemental Table I . We used human-specific PCR primers to verify insertion integrity of the different IFNG-BAC transgenes. Lines without full-length insertions were excluded from analysis. All animal studies were approved by the Institutional Animal Care and Use Committee of Vanderbilt University.
Cell purification and cultures

CD4
+ and CD8 + T cells were purified from splenocytes by positive selection per the manufacturer's instructions (Miltenyi Biotec). T cells were cultured with plate-bound 2 mg/ml anti-CD3 (hybridoma 2C11; American Type Culture Collection, Manassas, VA) and anti-CD28 (BD Biosciences). For Th1/Tc1 cultures, cells were cultured with 10 ng/ml IL-12 and 10 mg/ ml anti-IL4 (11B11 hybridoma; American Type Culture Collection). For Th2 cultures, CD4 + T cells were cultured with 20 ng/ml IL-4 and 10 mg/ml anti-IFN-g (hybridoma; American Type Culture Collection). In addition, cultures were harvested after 3 d and recultured with IL-2 for two additional d. Effector Th1/Tc1 cells were restimulated with plate-bound anti-CD3, 10 ng/ml IL-12, 10 ng/ml IL-18, 10 ng/ml IL-12, and 10 ng/ml IL-2 or 50 ng/ml PMA and 1 mM ionomycin. NK cells were purified from spleen by negative selection (Miltenyi Biotec).
Immunization
Five-week-old transgenic mice were immunized with 50 mg soluble OVA in CFA (Sigma-Aldrich) by i.p. injection. At day 10, mice received an additional boost of OVA in IFA. Splenocytes were harvested at day 35 for analysis. Splenocytes were either restimulated with 0.1 mg/ml OVA, 0.1 mg/ml hen egg lysozyme (HEL), or 10 mg/ml OVA 257-264 peptide. After 2 d, human and mouse IFN-g was determined in culture supernatants by ELISA. Alternatively, splenocytes were restimulated overnight with 10 ng/ ml IL-12 and 10 ng/ml IL-18. The next day, BD GolgiPlug (BD Biosciences) was added, and cells were cultured for an additional 6 h and analyzed by flow cytometry.
Results
Creation of 210-kb BAC DCNS216, DCNS24, and DCNS+20 transgenic mice Previous reports have detailed that mouse CNS222, mCNS26, mCNS+22, and mCNS+67 contribute to Ifng transcriptional regulation (19) . We used University of California, Santa Cruz genome alignments to identify respective orthologs at human CNS216, CNS24, CNS+20, and CNS+120. CNS24, CNS+20, and CNS +120 showed strong conservation in placental and nonplacental mammals, but we were unable to find a nonplacental ortholog to CNS216 (Fig. 1) . We verified correct enhancer ortholog location by referencing Th1 and Th2 DNase I hypersensitivity tracks. We next designed new IFNG-BAC transgenes with or without these CNSs. Although a 190-kb IFNG-BAC transgene correctly recapitulates developmental and signaling-dependent expression of IFNG, including dependence upon the transcription factors T-bet and STAT4 (14) , the 190-kb IFNG-BAC transgene does not contain CNS+120. We identified a new 210-kb IFNG-BAC transgene that differed mainly by the inclusion of CNS+120 (Fig. 1) . To assay functional roles of CNS216, CNS24, and CNS+20, we created new 210-kb IFNG-BACs with 1-kb deletions of CNS216 and CNS24 or a 3-kb deletion of CNS+20. A 3-kb region was chosen for CNS+20 to include all Th1-specific DNase I hypersensitivity sites as well as all regions homologous to mouse CNS+22. The exact locations of deletions, transgene locations, and homologous mouse locations are found in Supplemental Table I . We next created new transgenic mice with the full 210-kb IFNG-BAC transgene or with the DCNS216, DCNS24, or DCNS+20 transgenes.
Transgenic mice displayed no overt abnormalities were born at Mendelian ratios and gained weight at appropriate rates. Mouse IFN-g production was consistent among different transgenic lines and not affected by the presence of the transgene. The large size of BAC transgenes is thought to help protect against position integration effects but lead to potential partial integration effects (20) . We verified full integration of all transgenes by human-specific PCR of the BAC transgene from transgenic mouse genomic DNA ( Fig. 1 ). Transgenic mice without full integration were not analyzed further. We have previously observed that IFN-g expression from the 190-kb IFNG-BAC is dependent upon copy number (14) . We next analyzed relative copy number by quantitative PCR. Copy number of all new lines of BAC transgenic mice was consistent, equivalent to two copies in a 190-kb IFNG-BAC control. We next assayed for human IFN-g expression in the 210-kb IFNG-BAC, DCNS216, DCNS24, and DCNS+20 BAC transgenic mice.
CNS24 is necessary for IFN-g production by effector Th1 cells
We began our assays by using an in vitro tissue culture system. To test for expression in Th1 cells and repression in Th2 cells, CD4 + T cells were isolated and cultured under Th1-polarizing conditions (IL-12 and anti-IL-4) or Th2 conditions (IL-4) with plate-bound anti-CD3 and soluble anti-CD28 for 3 d. To test for expression in CD8 cells, CD8 + T cells were isolated and cultured under Th1-polarizing conditions (IL-12). At day 3, human and mouse IFN-g levels in cultures were assayed by ELISA. Alternatively, Th1 cells were cultured for two additional d in IL-2. On day 5, Th1 cells were restimulated with anti-CD3, IL-12, and IL-18 or IL-2 and IL-12 to test for defects specific to either TCR stimulation or coordinated cytokine stimulation. IFN-g was measured in cultures 2 d later.
We first assayed for human IFN-g expression from T cells with the 210-kb IFNG-BAC, the DCNS24, and the DCNS+20 IFNG-BAC transgenes. For comparison, we assayed for human IFN-g expression from previously created mice with the 190-kb IFNG-BAC transgene or 190-kb IFNG-BAC transgenes lacking CNS230 or CNS277, which have been previously described (14) . In day 3 Th1 cultures, human IFN-g culture supernatant concentrations did not significantly differ between 190-and 210-kb IFNG-BAC cultures. Further, presence or absence of CNS277, CNS24, or CNS+20 did not significantly change human IFN-g concentrations in Th1 or Th2 cultures ( Fig. 2A, left panel) . Control mouse IFN-g concentrations did not vary among transgenes ( Fig. 2A , right panel). As previously described (14) , removal of CNS230 led to a loss of detectable human IFN-g in cultures.
We continued our in vitro protocol and rested day 3 Th1 cultures in IL-2 for 2 d. CNS24 has been proposed as an IL-2-responsive The Journal of Immunologyelement (11) . Effector Th1 cells were restimulated with platebound anti-CD3, IL-12, and IL-18 or IL-12 and IL-2. Human IFN-g was measured in cultures 2 d later by ELISA. Human IFN-g levels did not significantly differ between Th1 cells with the 190-kb IFNG-BAC transgene or the 210-kb IFNG-BAC transgene (Fig. 2B) . Presence or absence of CNS277 or CNS+20 also did not significantly alter concentrations of human IFN-g in cultures.
As previously reported, and as seen in primary cultures, removal of CNS230 resulted in loss of detectable human IFN-g in restimulated Th1 cell cultures. However, unlike in primary cultures, removal of CNS24 resulted in a significant decrease in the concentration human IFN-g in culture supernatants of restimulated effector Th1 cells. The CNS24 defect was observed in both TCRrestimulated and IL-12-and IL-18-restimulated Th1 cells. As such, removal of CNS24 resulted in a loss of human IFN-g production by differentiated effector Th1 cells.
Lack of CNS216 leads to increased human IFN-g expression
We next investigated the role of CNS216 in the regulation of IFN-g in the human IFNG-BAC transgenic system. Using University of California, Santa Cruz genome alignments, we identified CNS216 as the ortholog of mouse CNS222. mCNS222 is necessary for Thy1.1 reporter expression from a murine BAC (9) . mCNS222 is also a T-bet-responsive enhancer in two independent cell-based reporter assays (9, 15) . As such, we hypothesized that CNS216 would be required for human IFN-g production in the IFNG-BAC transgenic system. We began by assaying human IFN-g expression from cultures of 210-kb IFNG-BAC or DCNS2 16 IFNG-BAC transgenic Th1 and Th2 cells. In direct contrast to our hypothesis, removal of CNS216 led to relatively higher human IFN-g in Th1 cultures compared with controls (Fig. 3A) . In addition, removal of CNS216 led to increased human IFN-g in Th2 cells. Control mouse IFN-g was appropriately repressed in Th2 cultures (Fig. 3A, right panel) . In this study and in previous studies of IFNG-BAC transgenic mice (14) , measurable human IFN-g above background levels was a phenotype unique to DCNS216 Th2 cultures. These results indicate that DCNS216 plays a key role repressing IFN-g expression in both Th1 and Th2 cell cultures.
We next assayed for human IFN-g in cultures of CD8 + T cells. We cultured 190-kb IFNG-BAC, DCNS277, and DCNS230 and 210-kb IFNG-BAC, DCNS216, DCNS24, and DCNS+20 transgenic CD8 + T cells for 3 d and measured human IFN-g by ELISA. As previously reported (14) , removal of CNS230 resulted in concentrations of human IFN-g below levels of detection (Fig.  3B) . Similar to Th1 cell cultures, removal of CNS216 resulted in relatively high concentrations of human IFN-g in CD8 + T cell cultures (Fig. 3B) . Choice of 190-kb IFNG-or 210-kb IFNG-BAC or presence or absence of CNS24 or CNS+20 did not significantly affect human IFN-g production by CD8
+ T cells under these culture conditions. To verify our results at the transcript level, we cultured transgenic CD4 + T cells for 3 d under Th1-polarizing conditions. After cDNA synthesis, we determined human IFNG and mouse Ifng transcript levels by quantitative PCR. We observed 
STAT4 and T-bet bind to the transgenic IFNG promoter
We next determined if any deletion was associated with altered T-bet and STAT4 binding to the IFNG-BAC promoter. We cultured 210-kb IFNG-BAC, DCNS216, DCNS24, and DCNS+20 transgenic CD4 + T cells for 3 d under Th1-polarizing conditions and processed cells for chromatin immunoprecipitation assays using Abs against T-bet, STAT4, or an IgG isotype control. We observed specific T-bet and STAT4 binding to the human IFNG and mouse Ifng promoters in BAC transgenic Th1 cells (Supplemental Fig. 1) . Levels of STAT4 binding to the transgenic IFNG and mouse Ifng promoters were essentially equivalent. Similarly, levels of T-bet binding to the transgenic IFNG and mouse Ifng promoters were essentially equivalent. Further, deletion of CNS216, CNS24, or CNS+20 did affect binding of STAT4 or T-bet to the IFNG promoter. As such, these deletions were not associated with changes T-bet or STAT4 binding to the IFNG promoter.
The CNS216 ortholog mCNS222 is required for Thy1.1 reporter expression from a mouse Ifng BAC transgene (9) . As mCNS222 and human CNS216 have opposing functions, we analyzed the mouse and human IFN g loci for obvious differences. We first compared conservation of the human IFNG locus (Supplemental Fig. 2A) . A small region of the human CNS216 was not conserved in the mouse and rat genomes, but was conserved in other rodents and mammals outside Muridae. We also observed a poorly conserved site within this region marked by Th1-specific DNase I hypersensitivity. As the DCNS216 deletion covered the murine-conserved portion of CNS216, we reanalyzed conserved transcription factor binding sites across CNS216. Analysis of transcription factor binding sites in the segment of CNS216 not conserved in mice identified a cluster of T-bet and Runx3 binding sites (Supplemental Fig. 2B ). To confirm the ability of the nonconserved segment of CNS216 and the poorly conserved CNS221 to bind transcription factors, we analyzed publicly available chromatin immunoprecipitation followed by sequencing data for binding of STAT4, STAT5A/B, and YY1 (21, 22) in Th1 cultures because of their known ability to regulate IFNG transcription. This analysis showed that STAT4 and STAT5 bound to both CNS221 and the portion of CNS216 not conserved in mice. These data identify CNS221 and the portion of CNS216 not conserved in mice as likely regulatory elements that may contribute to their observed functional differences.
CNS+20 is necessary for IFNG expression by memory Th1 cells
Our previous experiments relied upon in vitro maturation and polarization of Th cells using experimental procedures optimized for murine IFN-g production. Because previous reports have described differences in long-range chromatin modifications of the mouse Ifng locus during in vivo and in vitro Th1 polarization (15), we addressed the necessary functional requirements of human IFNG distal regulatory elements in vivo. Mice were immunized by i.p. injection with OVA in CFA and boosted at day 10 with OVA in IFA. At day 35, splenocytes were isolated and restimulated with irrelevant protein, HEL, OVA protein, or OVA 257-264 SIIN-FEKL peptide, which is recognized by CD8 + T cells on the C57BL/6 background (23). After 2 d, human and mouse IFN-g concentrations in cultures were determined by ELISA (Fig. 4) . Human and murine IFN-g production was Ag specific and not observed in HEL-stimulated cultures. Concentrations of human IFN-g were higher in DCNS216 cultures when restimulated with either OVA or OVA (257-264) peptide relative to controls. Consistent with results from in vitro-generated Th1 cells, removal of CNS24 resulted in a significant decrease in human IFN-g production in the Ag-specific memory responses. Further, although human IFN-g production by in vitro-generated DCNS+20 Th1 cells did not significantly differ from controls, human IFN-g concentrations in the cultures of DCNS+20 T cells were significantly lower in response to Ag-specific restimulation of in vivo-generated memory cells. These results demonstrate a necessary role for CNS+20 in memory responses in vivo.
Among T cells, IFN-g expression in response to IL-12 and IL-18 stimulation is restricted to effector/memory Th1/Tc1 lineages. Therefore, we analyzed human IFN-g expression by freshly isolated CD4 + and CD8 + T cells after stimulation with IL-12 and IL-18 overnight. Eighteen hours later, single cells producing human and mouse IFN-g were quantified by flow cytometry ( NKT cells require CNS+20 for human IFN-g production NKT cells represent an innate-like T cell subset arising from the T cell lineage but that express NK cell markers. Upon recognition of glycolipid Ags, NKT cells rapidly express IFN-g and other cytokines characteristic of multiple T cell lineages (24) . Therefore, we determined which distal regulatory elements were required for IFNG expression by NKT cells. We first assayed NKT cell expression after Ag-specific stimulation. Splenocytes from 210-kb IFNG-BAC, DCNS216, DCNS24, and DCNS+20 transgenic mice were isolated and stimulated with the glycolipid a-galactosylceramide or a mock stimulus. After 2 d, human and mouse IFN-g concentrations in cultures were determined by ELISA (Fig. 6A) . Concentrations of human IFN-g did not significantly differ among 210-kb IFNG-BAC, DCNS216, or DCNS24 cultures. In contrast, removal of CNS+20 resulted in a marked decrease in production of human IFN-g.
To directly compare NKT cell regulation with T and NK cell regulation of the IFNG-BAC transgene, we examined NKT cell expression of human and mouse IFN-g after stimulation with IL-12 and IL-18. Isolated splenocytes were stimulated with IL-12 and IL-18 for 16 h and analyzed by intracellular cytokine staining (Fig. 6B) . To identify NKT cell populations, we used a tetramer specific for the NKT cell receptor CD1d. Cells were gated on MHC class II-negative populations to remove nonspecific tetramer staining. Percentages of human IFN-g-positive cells did not vary among 210-kb IFNG-BAC, DCNS216, and DCNS24 transgenic NKT cells. By contrast, we did not detect DCNS+20 transgenic NKT cells positive for human IFN-g. These results are consistent with a necessary role for CNS+20, but not other CNS, for NKT cells to express human IFN-g from the IFNG-BAC transgene.
NK cells partially require CNS216, CNS24, and CNS+20
In previous work, we demonstrated that CNS230 is not required for human IFN-g expression by NK cells (14) . Human CNS24 is acetylated in NK cells and is an enhancer in reporter assays using human PBMCs (11) . Further, NK cells immigrate to the periphery fully able to rapidly produce IFN-g, much like effector Th1 cells, which required CNS24 for human IFN-g expression. As such, we hypothesized that CNS24 was required for human IFN-g expression by NK cells. To determine distal regulatory usage by NK cells, purified 210-kb IFNG-BAC, DCNS216, DCNS24, and DCNS+20 transgenic NK cells were stimulated with IL-12 and IL-18. After 2 d, we measured human and mouse IFN-g in cultures (Fig. 7A) . In contrast to T cells, removal of CNS216 resulted in a significant decrease in human IFN-g concentrations in NK cell cultures. In addition, removal of CNS24 or CNS+20 resulted in a significant decrease in human IFN-g concentrations in culture supernatants compared with controls. Concentrations of human IFN-g in NK cell-culture supernatants were noticeably higher than concentrations of human IFN-g in T cell cultures under identical stimulation conditions (Fig. 2B) . We verified that cultures were 95% pure DX5 + NK1.1 + (Fig. 7B) . The high concentrations of human IFN-g in the cultures and functional requirements for CNS216 suggests that NK cell regulation of the BAC transgene differed from T cell regulation.
We directly compared distal regulatory element usage in T cells and NK cells by intracellular cytokine staining of IL-12-and IL-18-stimulated splenocytes from immunized transgenic mice. After gating on mouse IFN-g + CD8 2 populations, we directly compared T cells and NK cells by comparing CD4 + T cells to CD4 2 DX5 + cells (Fig. 7C) . In 210-kb IFNG BAC NK cells, 40% of cells were human IFN-g + (Fig. 7D ), similar to expression by T cells. Consistent with measurements of protein concentrations, each of the CNS216, CNS24, and CNS+20 deletions individually resulted in a slight decrease in percentages of human IFN-g + NK cells (Fig.  7D) . Taken together, CNS216, CNS24, and CNS+20 all contribute to a fraction of the total human IFN-g + expression by NK cells but have markedly different functions in CD4 + and CD8 + T cells and NKT cells.
Discussion
In this study, we determined the necessary functional roles of IFNG distal regulatory elements CNS216, CNS24, CNS+20, and CNS+120 using a BAC transgenic system. In T cells, these distal regulatory elements all have discrete functions. CNS216 is a repressor of IFN-g expression in both Th1 and Th2 cells. CNS24 is necessary for IFN-g expression by effector Th1 cells in response to secondary TCR stimulation. CNS+20 is necessary for memory responses in vivo. In contrast, only CNS+20 is required by NKT cells to produce human IFN-g in response to Ag stimulation. Unlike T cells and NKT cells, CNS216, CNS24, and CNS+20 each are partially required for IFNG expression in NK cells, and removal of no individual distal regulatory element completely abolishes human IFN-g expression. As such, NK, NKT, and Th1 cells employ very different usage of distal regulatory elements to achieve lineage-specific IFNG transcription. CNSs at 230, 24, and +20 kb from the IFNG start site are necessary for expression of human IFN-g. In an earlier report, we used 40-and 80-kb deletions in the IFNG-BAC transgenic model to identify the 230 to +20 kb region as necessary for IFNG expression, whereas regions outside this core regulatory element, 280 to 240 kb and +20 to +100 kb, were dispensable (14) . CNS230, CNS24, and CNS+20 show clear nonplacental orthologs in our conservation analysis. In addition, CNS230, CNS24, and CNS+20 possess Th1-specific DNase I hypersensitive sites. Distal regulatory regions that are either not conserved in nonplacental mammals or do not show Th1-specific DNase I hypersensitivity were not required for IFNG expression. Thus, in our model system, the combination of Th1-specific DNase I hyper- sensitivity and nonplacental mammalian conservation appears to separate necessary distal regulatory elements from distal regulatory elements that are not necessary for IFNG expression. Consistent with our results, other reports have demonstrated functional roles for CNS24 in responding to Stat5a, Stat5b, NFAT, and T-bet transcription factors (11-13, 18, 19) . IL-2 signaling through Jak3 induces Stat5 binding at CNS24 and is important for remodeling of the Ifng locus after 72 h of culture (12) , consistent with a role for CNS24 in effector cultures. CNS+20 has little enhancer activity on its own, but acts synergistically with CNS24 in reporter assays (17) and loops into CNS24 upon Th1 differentiation (25) . In the IFNG-BAC transgenic system, CNS+20 is required for IFN-g expression from in vivo-generated memory cells. One model to explain these observations would be that IFNG distal regulation has successive requirements during T cell maturation. As Th1 cells develop further away from an initial polarization signal, more distal regulatory elements would become necessary. In this model, CNS230 is required for human IFN-g expression in primary cultures and later stages of differentiation, CNS24 is required in effector Th1 cells, and CNS+20 is required in memory Th1 cells. An alternative hypothesis would be that there are yet-undefined in vivo factors that regulate IFN-g expression and distal regulatory element use. In this model, an in vivo factor allows CNS24 to be dispensable in primary cultures and makes CNS+20 absolutely required during in vivo differentiation. Future work will differentiate between these hypothesizes.
Counter to our initial hypothesis, removing CNS216 leads to relatively high human IFN-g expression by both Th1 and Th2 cells and is necessary for IFN-g expression only in NK cells. These results are surprising because in a similar BAC transgenic system, the murine CNS216 ortholog is absolutely necessary for transcription of an Ifng-BAC transgene Thy1.1 reporter by both T cells and NK cells (9) . However, CNS216 is not conserved beyond nonplacental mammals (Fig. 1) , not required for IFN-g expression in our human BAC system, and therefore not universally required for IFN-g expression by T cells. Numerous reports have demonstrated species-specific roles of distal regulatory elements (5, 26, 27) . Thus, it is likely that the CNS216 ortholog, mCNS222, is required for murine IFN-g expression in T cells, whereas CNS216 plays an opposing role in human IFNG regulation, repressing IFN-g expression. Indeed, the mouse IFN-g locus has undergone substantial rearrangements relative to nonrodent species (28) . Future comparison of the mouse and human IFN-g loci will provide additional insights into the speciesspecific functions of distal regulatory elements.
Although regulation of human IFN-g expression from the 190-kb IFNG-BAC transgene correctly depends upon the transcription factors T-bet and STAT4 (14) and is Th1/Th2 selective, it is likely that regulation of IFNG-BAC transgenes does not perfectly mirror regulation in humans. Analysis is based upon the assumption that regulation of transgenic human IFN-g in a mouse fully recapitulates regulation in the endogenous human genome, which may not be true. As such, these findings need to be confirmed in humans.
Transgenic T cells with a 190-or 210-kb IFNG-BAC transgene express human IFN-g at equivalent levels. The two transgenes differ mainly by the inclusion of CNS+120 in the 210-kb IFNG-BAC. CNS+120 is thought to facilitate three-dimensional organization of the IFNG locus via CCCTC-binding factor (CTCF) binding at CNS+120, CNS263, and the IFNG first intron (29, 30) . CTCF has been described as a transcriptional activator (31), insulator (32) , and repressor (33) . However, most of these functional studies come from reporter assay systems that do not take genomic context into account, and a relevant question is the exact function of CTCF binding sites in the genome. Arguing against an insulating role of the +120 CTCF site in the IFNG locus are previous experiments reporting copy-number dependence for 190-kb IFNG-BAC transgenes (14) and equivalent expression between 190-and 210-kb IFNG BAC transgenes. Another hypothesis would be that the +120 and 263 kb CTCF sites serve to bring the IFNG locus into close physical location to other genes in the surrounding regions. IFNG is adjacent to IL22 and IL26 (34), both of which are expressed in Th17 cell subsets upon TCR signaling. IFNG locus CTCF sites may play a role in coregulation of IFNG, IL22, and IL26. Alternatively, the CTCF sites may govern intrachromosomal looping interactions, such as those observed between the Ifng locus and the Il4 locus (25) .
Transgene deletion effects are dissimilar between NK cells and T cells. In NK cell assays, each distal regulatory element is required for a fraction of human IFN-g expression. These results support models proposing that distal regulation serves to allow expression under suboptimal signaling conditions (7) and functions in evo- lution to modify the level of gene expression in individual species (27) . A second model is that distal regulatory elements are both cell type and stimulus selective and function in evolution by allowing changes in the timing and location of gene expression (5, 27) . This model is consistent with distal regulatory element usage in T cells. In T cell assays, CNS230 is needed in primary cultures, CNS24 in effector cultures, and CNS+20 in memory experiments. Thus, our results support both models of distal regulation. More importantly, choice of cell type determines which model is supported. These results illustrate the importance of analyzing multiple cell types and phenotypes when analyzing the key contributions distal regulatory elements make to achieve proper gene regulation.
